PAVmed (PAVM) Preferred Shares (2017 - 2025)

PAVmed has reported Preferred Shares for 9 years, with the latest figure at $3.7 million in Q4 2025.

• For the quarter ending Q4 2025, Preferred Shares changed N/A year-over-year to $3.7 million; the trailing twelve-month figure through Dec 2025 stood at $3.7 million (changed N/A YoY), and the FY2025 full-year result was $3.7 million, changed N/A from the prior year.
• Preferred Shares for Q4 2025 stood at $3.7 million, up from $3.6 million in the prior quarter.
• The five-year high for Preferred Shares was $3.7 million in Q4 2025, with the low at $2.4 million in Q3 2021.
• Average Preferred Shares over 5 years is $2.9 million, with a median of $2.8 million recorded in 2023.
• Year-over-year, Preferred Shares dropped 4.65% in 2021 and gained 11.56% in 2022.
• Tracing PAVM's Preferred Shares over 5 years: stood at $2.4 million in 2021, then increased by 11.41% to $2.7 million in 2022, then climbed by 11.06% to $3.0 million in 2023, then climbed by 5.28% to $3.2 million in 2024, then advanced by 16.31% to $3.7 million in 2025.
• The last three Preferred Shares figures came in at $3.7 million (Q4 2025), $3.6 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.

Peer Comparison